Business Wars Encore: Diet Wars | Dieting 3.0 | 5
18 snips
Apr 19, 2023 Emma Court, a health reporter from Bloomberg News, breaks down the transformation of the weight loss industry, highlighting the shift from traditional programs to digital platforms and the impact of medications like Ozempic. Matthew Schneier, features writer at New York Magazine, discusses his article on the cultural implications of these drugs, addressing ethical dilemmas, celebrity influence, and the changing perceptions of food in our lives. Together, they explore what dieting looks like in today's society and the future of weight management.
AI Snips
Chapters
Books
Transcript
Episode notes
Weight Loss Companies Struggling
- Jenny Craig faces financial challenges and seeks a buyer.
- Weight Watchers rebranded as WW to focus on wellness, but this hasn't been very successful.
Weight Watchers Embraces Medication
- Weight Watchers' acquisition of Sequence, a telehealth company prescribing weight loss drugs, is a departure from their traditional approach.
- This move reflects the growing demand for these medications.
Weight Watchers as Trusted Source
- Weight Watchers positions itself as a trusted source in the weight loss medication space.
- They aim to provide a reputable alternative to less credible telehealth companies.
